Study ID: TAL-MB-100
Study Title
- A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
Teva Identifier
- TAL-MB-100
ClinicalTrials.gov Identifier
- NCT00868361
Study Status
- Terminated
Trial Condition(s)
- Healthy
Interventions
- Drug: Talampanel (non-radiolabeled), [14C] Talampanel
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 05/01/2009 - 09/01/2009
Phase
- Phase 1
Study Type
Interventional
